According to the Rybelsus Summary of Product Characteristics (SmPC), co-administration with omeprazole produces no clinically relevant change in semaglutide exposure, and no dose adjustment of Rybelsus is required when taken with PPIs
Many patients are on a combination of an SGLT2 inhibitor with a GLP-1 receptor agonist or tirzepatide (a dual agonist) and have incredible success without adverse reactions, but we are still figuring out the patient characteristics that would put them at higher risk of poor outcomes. Bagley is the senior editor of Endocrine News
They came in louder over the last twelve months, and louder still in the last few weeks
One domain is a GC-rich sequence, the other is a small functional upstream open reading frame (uORF)
doi:10.4103/1463-1741.140499
Exploring the Impact of Vitamin B12 Injections on Elderly Cognitive Decline and Overall Health As the global population ages, the concern around aging-related health issues, especially cognitive decline, intensifies